Related Experiment Video
Updated: Aug 6, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Combination of Oral Doxycycline and Rifampin for Pan-Drug Resistant Klebsiella pneumoniae Infection: A Case Report
Ali Akbar Heydari1, Sepideh Elyasi2, Farshad Abedi2
1Research Center for Infection Control & Hand Hygiene, Department of Infectious Diseases, Imam Reza Hospital Mashhad University of Medical Sciences Mashhad Iran.
Abstract:
Pan-drug resistant Klebsiella pneumoniae is a major therapeutic challenge, particularly when standard last-line agents are unavailable or contraindicated. We report a 45-year-old man with multifocal osteomyelitis and persistent purulent wound discharge despite broad-spectrum antibiotics, repeated debridement, and two sequential amputations. Wound culture grew K. pneumoniae resistant to all antibiotics tested in the locally available susceptibility panel. Initial treatment with colistin plus extended-infusion meropenem was discontinued because of acute kidney injury. Oral doxycycline 100 mg twice daily combined with rifampin 600 mg once daily was then initiated as salvage therapy, resulting in rapid resolution of purulent discharge and marked reduction in inflammatory markers. This case suggests that oral doxycycline plus rifampin may represent a low-cost and accessible salvage option for highly resistant K. pneumoniae infections when standard therapies are unavailable or not tolerated.
Insights
Pan-drug resistant Klebsiella pneumoniae infections pose a significant challenge. Oral doxycycline and rifampin offer a potential low-cost salvage therapy when standard treatments fail or are contraindicated.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Pan-drug resistant Klebsiella pneumoniae presents a critical therapeutic hurdle.
- Standard last-line antibiotics may be unavailable or cause adverse effects.
- Osteomyelitis and chronic wound infections are severe manifestations.
Purpose of the Study:
- To report a case of highly resistant Klebsiella pneumoniae infection.
- To evaluate salvage therapy options when standard treatments are not feasible.
- To highlight potential alternative treatments for challenging bacterial infections.
Main Methods:
- A case study of a 45-year-old male patient with multifocal osteomyelitis.
- Initial treatment failure with colistin and meropenem due to acute kidney injury.
- Administration of oral doxycycline and rifampin as salvage therapy.
Main Results:
- The patient experienced rapid resolution of purulent discharge.
- Significant reduction in inflammatory markers was observed.
- Doxycycline and rifampin demonstrated efficacy in a salvage setting.
Conclusions:
- Oral doxycycline plus rifampin may serve as a viable, accessible, and low-cost salvage option.
- This combination therapy is a potential alternative for pan-drug resistant Klebsiella pneumoniae infections.
- Effective management strategies are crucial when standard therapies are unavailable or contraindicated.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management
Inhibitors of Bacterial DNA Synthesis
Rocky Mountain Spotted Fever
Clinical Significance of Antibiotic Resistance
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
